Covered recipient · General Payments record
NICHOLAS DAVID MONTGOMERY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$3,104.98
- Reported across 195 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $254.31 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $89.93 | 5 |
| Xeris Pharmaceuticals, Inc. | $41.20 | 2 |
| Lilly USA, LLC | $29.19 | 2 |
| Astellas Pharma US Inc | $18.45 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.59 | 1 |
| PFIZER INC. | $15.76 | 1 |
| Novo Nordisk AS | $15.39 | 1 |
| CeQur Corporation | $13.99 | 1 |
| Amgen Inc. | $13.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.78 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204993404 | CMS |
| ABBVIE INC. | $17.84 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204993408 | CMS |
| ABBVIE INC. | $15.33 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204993412 | CMS |
| ABBVIE INC. | $15.78 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204993416 | CMS |
| ABBVIE INC. | $25.20 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204993420 | CMS |
| Amgen Inc. | $13.81 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228732850 | CMS |
| Astellas Pharma US Inc | $18.45 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238596786 | CMS |
| CeQur Corporation | $13.99 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228694625 | CMS |
| Lilly USA, LLC | $15.66 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187235205 | CMS |
| Lilly USA, LLC | $13.53 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187235203 | CMS |
| Novo Nordisk Inc | $15.39 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188521873 | CMS |
| PFIZER INC. | $15.76 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229116330 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.59 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232125724 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.58 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250200638 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.62 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250200640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.